Page last updated: 2024-08-26

bosentan anhydrous and Coronary Disease

bosentan anhydrous has been researched along with Coronary Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCulloch, J; Patel, TR1
Clozel, M; Fleisch, M; Jones, CR; Kaufmann, U; Lüscher, TF; Meier, B; Noll, G; Schmitt, R; Shaw, S; Wenzel, RR1
Barton, M; Glodny, B1

Trials

1 trial(s) available for bosentan anhydrous and Coronary Disease

ArticleYear
Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease.
    Circulation, 1998, Nov-24, Volume: 98, Issue:21

    Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Bosentan; Coronary Disease; Coronary Vessels; Double-Blind Method; Endothelins; Heart Rate; Hemodynamics; Humans; Middle Aged; Sulfonamides

1998

Other Studies

2 other study(ies) available for bosentan anhydrous and Coronary Disease

ArticleYear
Postischemic hypoperfusion in transient global ischemia: a role for endothelins?
    Journal of cardiovascular pharmacology, 1995, Volume: 26 Suppl 3

    Topics: Animals; Arterial Occlusive Diseases; Bosentan; Cerebrovascular Circulation; Coronary Disease; Endothelins; Hypotension; Ischemic Attack, Transient; Male; Rats; Rats, Sprague-Dawley; Sulfonamides

1995
Endothelin receptor blockade and nitric oxide bioactivity.
    Cardiovascular research, 2001, Volume: 52, Issue:1

    Topics: Acetylcholine; Bosentan; Coronary Artery Bypass; Coronary Disease; Endothelin Receptor Antagonists; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Nitric Oxide; Oligopeptides; Peptides, Cyclic; Piperidines; Receptors, Endothelin; Sulfonamides; Vasodilation; Vasodilator Agents

2001